H.E Chief Olusegun Obasanjo
UNDER THE HIGH PATRONAGE OF
HIS EXCELLENCY CHIEF OLUSEGUN OBASANJO GCFR, Ph.D

( Former President of The Federal Republic of Nigeria )

Dr. Satyendra Katewa, MBBS Dch DNB(Paediatrics)

Head, Dept. of Paediatric Hematology Oncology and Bone Marrow Transplant, Manipal Hospital, Jaipur, Rajasthan

Dr. Satyendra Katewa did his Graduation from Sardar Patel Medical College, Bikaner and pursued his post-graduation in paediatric from the same institute. He completed his super specialisation in paediatric haemato-oncology and bone marrow transplant from prestigious national and international institutions like Sir Ganga Ram Hospital, Delhi, India; The Hospital for Sick Children “Sickkids” Toronto, Canada (Clinical associate) and The Cincinnati Children Hospital, Ohio, USA (Fellow Observer). These are the most prestigious institutions across the globe for BMT in kids.

He is one of the very few haemato-oncologist who do BMT exclusively for children. He carries a vast experience of doing more than 350 allogeneic haematopoietic stem cell transplants. His subjects of interests are less than 100% matched donor Bone Marrow Transplants for diseases like thalassemia, Sickle cell disease, primary immunodeficiency diseases, blood cancer, brain tumours, bone and soft tissue cancers.

His special interests are haploidentical HSCT for hemoglobinopathies, performing 2nd transplant after failed first one and immunological manipulation post BMT and cell therapies pre-BMT in an attempt to reduce relapses post BMT in leukemia patients.

Before coming to India, Dr Satyendra Katewa has served as a faculty at Hospital for Sick Children “SickKids”, Toronto and Canada and that makes his experience exhaustive and fruitful. Bone Marrow Transplant program at SickKids hospital does lots of transplants for Sickle Cell Disease, primarily matched sibling (100% HLA matched) and matched unrelated BMT (100% HLA matched). Dr Satyendra Katewa started the haploidentical BMT (50% HLA matched) program for Sickle Cell Anemia patients in India.

His experience for haploidentical HSCT in hemoglobinopathies (Sickle Cell and Thalassemia) is vast and second to none.


Session(s):
2-Nov-2019
Transplant with Haploidentical Donors: A New Innovation
Parallel Session – Room 2A,
Main Congress Program

ACSCD Congress Sponsors/Partners

Host Ministry
Host City
In Association With
Supported By
Innovator Partner
Advocate Partner
Patron Partner
Charity Partner
WOSC Symposium Partner
Official Research(CRO) Partner
Knowledge Partners
Bank Partner
Supporting Organizations
Premier Media Partners
Official Media Partner
International Media Partners
Official Print Partner
Venue Partner

Stay Update on the Conference

Enter email below to stay updated with the latest info on the conference.